» Articles » PMID: 20453114

A Hypoechoic Pattern of the Thyroid at Ultrasound Does Not Indicate Autoimmune Thyroid Diseases in Patients with Morbid Obesity

Overview
Specialty Endocrinology
Date 2010 May 11
PMID 20453114
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Thyroid ultrasound (US) scan is a valuable tool for diagnosing thyroid diseases. In autoimmune thyroid disease (AITD), an hypoechoic pattern of the thyroid at US is related to circulating thyroid antibodies (Abs). The aim of this study was to evaluate the diagnostic accuracy of thyroid US for the detection of AITD in patients with morbid obesity.

Design: Thyroid US scans showing an hypoechoic pattern of the thyroid were collected from 105 morbid obese patients (body mass index (BMI) >40 kg/m(2)) and 105 non-obese patients (BMI<or=30 kg/m(2)).

Results: A thyroid hypoechoic pattern at US was consistent with clinical/biochemical features of AITD in 90/105 (85.7%) non-obese patients and in 22/105 (20.9%) morbid-obese patients (P<0.0001). By performing a complete thyroid work-up, including clinical examination, thyroid morphology, serum hormones, and auto-Ab measurements, the discrepancy between the US pattern and the results of the thyroid Ab tests was justified in 6/15 non-obese patients, and only in 1/83 morbid obese patients. Thus, an unexplained hypoechoic pattern of the thyroid at US, defined as negative tests for thyroid Ab and absence of justifying thyroid disturbances, was found in 2/105 (1.9%) non-obese patients and in 68/105 (64.8%) morbid obese patients (P<0.0001).

Conclusions: Our results suggest that i) morbid obesity may affect thyroid morphology, and ii) an hypoechoic pattern of the thyroid at US, a well-established parameter for diagnosing AITD, has a poor diagnostic accuracy when patients with morbid obesity are taken into account.

Citing Articles

Subclinical Hypothyroidism in Patients with Obesity and Metabolic Syndrome: A Narrative Review.

Biondi B Nutrients. 2024; 16(1).

PMID: 38201918 PMC: 10780356. DOI: 10.3390/nu16010087.


Fifteen Years of Iodine Prophylaxis in Italy: Results of a Nationwide Surveillance (Period 2015-2019).

De Angelis S, Medda E, Rotondi D, Masocco M, Minardi V, Contoli B J Clin Endocrinol Metab. 2023; 109(2):e495-e507.

PMID: 37820735 PMC: 10795908. DOI: 10.1210/clinem/dgad593.


A first-trimester serum TSH in the 4-10 mIU/L range is associated with obstetric complications in thyroid peroxidase antibody-negative women.

Magri F, Bellingeri C, De Maggio I, Croce L, Coperchini F, Rotondi M J Endocrinol Invest. 2022; 46(7):1407-1414.

PMID: 36562959 DOI: 10.1007/s40618-022-01996-z.


Association between High Normal TSH Levels and Obesity in Women with Anti-Thyroid Autoantibodies (ATAs).

Velluzzi F, Pisanu S, Galletta M, Fosci M, Secci G, Deledda A J Clin Med. 2022; 11(17).

PMID: 36079055 PMC: 9457091. DOI: 10.3390/jcm11175125.


Possible added value of thyroglobulin antibody (TgAb) testing in the evaluation of thyroidal status of subjects with overweight or obesity.

Fierabracci P, Basolo A, Scartabelli G, Bechi Genzano S, Salvetti G, Sotgia G J Endocrinol Invest. 2022; 45(11):2077-2084.

PMID: 35781791 PMC: 9525400. DOI: 10.1007/s40618-022-01839-x.